Article Details
Retrieved on: 2025-04-22 20:46:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Unity Biotechnology's financial results and updates on their clinical study of UBX1325, focusing on diabetic macular edema (DME) and age-related macular degeneration (AMD). Tags reflect the company's location, NASDAQ listing, and associations with Unity Technologies.
Article found on: www.manilatimes.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here